The Cannabis Administration and Opportunity Act is a bill that outlines an extensive framework for the decriminalization of cannabis, enhancing public safety, and respecting states' rights. It addresses areas like research, public health, economic development through trust funds, federal cannabis regulation, workplace safety, banking, community development, and other miscellaneous provisions, emphasizing cannabis legalization's societal impacts and fostering equitable opportunities.

The findings highlight the negative impact of cannabis prohibition on communities of color, the economic growth of the legal cannabis industry, and the challenges faced by minorities in entering the market due to historical inequalities and legal barriers. Despite reforms in many states to allow legal cannabis use, federal restrictions and high costs continue to limit opportunities for minority-owned businesses.

In this Act, cannabis and cannabis product are defined according to the Federal Food, Drug, and Cosmetic Act. A cannabis offense refers to crimes involving cannabis that are no longer punishable by federal or state law. An Indian Tribe is identified as the governing body of any federally recognized Native American or Alaska Native group, as listed under the Federally Recognized Indian Tribe List Act of 1994.

The section outlines the decriminalization of cannabis, removing it from the federal list of controlled substances and amending various existing laws accordingly. It also sets retroactive policies for pending and past cannabis-related offenses and includes special rules for federal employee drug testing concerning cannabis.

The bill section proposes transferring cannabis-related enforcement duties from the DEA to the Department of Health and Human Services and the Department of the Treasury. It also renames the Alcohol and Tobacco Tax and Trade Bureau to include cannabis and requires a memorandum of understanding between agencies to reduce compliance burdens for the cannabis industry.

The section outlines regulations regarding the transportation of cannabis across states. It allows states to apply their local laws to cannabis arriving within their borders, prohibits its shipment if it's intended to violate a state's law, ensures states or tribes cannot block cannabis transportation through their area, and modifies existing law to include cannabis by aligning it with rules for intoxicating liquors.

The section outlines laws and penalties related to the illegal handling of cannabis, requiring permits to grow, transport, or sell large amounts, and imposes fines or jail time for violations. It also mandates tracking and tracing regulations to prevent illicit activities, including keeping records for inspection, while consulting with Indian Tribes and considering state practices.

The section directs the Comptroller General of the United States to study the effects of cannabis legalization in states, focusing on law enforcement, employment, healthcare, and tax revenue. The findings must be shared with several Congressional committees within two years, with a full report to follow later.

The bill section directs the Secretary of Health and Human Services to conduct or support research on the effects and medical uses of cannabis, addressing various topics such as its impact on different health conditions and methods of delivery. It mandates annual reports to Congress for four years and allocates $200 million annually from 2025 to 2029 for this research.

The section amends the Public Health Service Act to enhance data collection and studies on the health effects of cannabis, stimulants, and multiple substance use; it increases the funding for these activities from $496 million to $596 million annually for fiscal years 2025 to 2029 and provides additional funding of $100 million per year for the same period.

The bill section provides funding for grants to organizations aimed at preventing and reducing underage cannabis use. Eligible recipients, such as state and local governments, tribal organizations, and nonprofits, can use the funds for community and school-based programs, educational campaigns, data collection, and other strategies to combat underage cannabis use, with priority given to underserved and disproportionately affected communities.

The section allows the Secretary to provide grants, contracts, and agreements to various eligible entities, such as states and nonprofit organizations, to prevent and reduce underage cannabis use. Funds awarded must be used to support culturally appropriate programs, educate communities, and strengthen collaboration, with priority given to underserved communities and those with high cannabis use rates.

The bill section outlines a plan for the Secretary of Health and Human Services, along with other agencies, to run national media and educational campaigns about the dangers of underage cannabis use and cannabis-impaired driving. It mandates creating annual reports on these efforts and allocates $5,000,000 annually from 2025 to 2029 for the campaigns.

The bill mandates the Secretary of Health and Human Services to work with other officials to increase the types of cannabis products available for research, ensuring diverse options that mimic consumer-available products. Additionally, $275 million is allocated annually from 2025 to 2029 for this purpose, and a briefing to Congress is required within one year of the bill's enactment.

The Trans-NIH Cannabis Research Consortium is established by the Director of NIH to organize cannabis research across the NIH. The consortium will set research priorities, look for collaboration opportunities, and support new cannabis researchers, while regularly consulting with experts and reporting to Congress and the public on their activities and progress.

The Trans-NIH Cannabis Research Consortium, overseen by the Director of the National Institute on Drug Abuse, will coordinate cannabis research efforts across various national research institutes. Its duties include setting research priorities, identifying collaboration opportunities, fostering new cannabis researchers, and providing biannual reports on research projects, strategic initiatives, career awards, and the diversity of research participants.

The section establishes a Cannabis Research Interagency Advisory Committee within the Department of Health and Human Services to coordinate federal research and activities related to cannabis. The committee includes members from various federal agencies and is responsible for overseeing cannabis research, identifying barriers, making recommendations, and providing annual updates on progress and strategic plans to Congress and the President.

The Secretary of Health and Human Services is tasked with giving grants to public and nonprofit groups to research the health effects of cannabis, especially in different populations such as children and pregnant women. The grants will focus on understanding both the benefits and risks of cannabis, and priority will be given to minority-serving institutions. Reports on this research must be publicly shared, and $200 million per year will be allocated for these efforts from 2025 to 2029.

The Department of Veterans Affairs is required to conduct clinical trials on veterans with chronic pain or PTSD to study the effects of medical cannabis on various health outcomes, ensuring a diverse representation and excluding veterans at high risk of substance use disorder or with certain health conditions. The trials will explore different forms of cannabis with varied THC to CBD ratios, and data will be preserved for future research, with periodic reports submitted on the implementation progress.

The bill establishes a grant program to help colleges and universities build facilities and resources for cannabis research. Priority for these grants will be given to schools with limited resources and those with experience in cannabis studies, and the funds can be used for tasks like growing cannabis, buying lab equipment, and hiring staff.

The Cannabis Research Infrastructure Grant Program establishes a process where the Secretary awards competitive grants to colleges and universities, helping them build or improve facilities and resources for cannabis research. It prioritizes certain schools, such as under-resourced colleges and those with cannabis research experience, and grants can be used for activities like cultivating cannabis, upgrading lab facilities, and recruiting staff.

The section provides definitions for terms used in the document: Administrator refers to the head of the National Highway Traffic Safety Administration, Secretary refers to the Secretary of Transportation, and THC stands for tetrahydrocannabinol.

The Cannabis-Impaired Driving Research section outlines plans for the collection and analysis of data on driving under the influence of cannabis. Within one year of the act's passage, a National Roadside Survey will begin gathering data, and within three years, a study will be conducted to assess the risks and effects of cannabis-impaired driving, including its correlation with THC levels and interactions with other substances. The findings from these initiatives will be reported to relevant congressional committees.

The section mandates that the Secretary of Transportation research and implement strategies to educate the public about the dangers of cannabis-impaired driving. This includes creating best practices for preventing it, launching national campaigns, evaluating their effectiveness every three years, and reporting to Congress with recommendations and analyses.

The section establishes a program to provide grants to U.S. states for preventing cannabis-impaired driving, including training public safety personnel, improving toxicology labs, and conducting educational campaigns. States must comply with certain conditions, such as implementing best practices and data reporting, to receive funding, and the federal government will cover a significant portion of costs, which decreases if states do not enact open container laws for cannabis products.

The State Cannabis-Impaired Driving Prevention Grant Program aims to provide financial support for states to create programs that prevent cannabis-related impaired driving. States can use these funds for activities such as training law enforcement, collecting data on cannabis use while driving, and educating the public, but they must meet certain eligibility requirements and adhere to funding conditions, such as implementing open container laws for cannabis products to maintain federal funding levels.

The section mandates that within three years from the act’s enactment, and every two years afterwards, the Secretary must decide if it's possible to set a national standard for determining cannabis-related driving impairment. If feasible, the Secretary is required to create regulations for a model marijuana impairment standard within a year of the decision.

In section 226, the bill allocates $30 million a year from 2025 to 2029 to fund sections 222 and 223, using money from the Treasury that hasn't been assigned for other purposes.

The text describes provisions for establishing a Cannabis Justice Office to manage programs like the Community Reinvestment Grant Program, which supports individuals impacted by the War on Drugs through services like job training and legal aid. It also outlines the Cannabis Opportunity Program and Equitable Licensing Grant Program, which aim to provide financial assistance and create fair licensing for cannabis businesses in eligible states or tribal areas, with a focus on those from disadvantaged backgrounds.

The Cannabis Justice Office is being created within the Office of Justice Programs and will be led by a Director appointed by the Assistant Attorney General. The office will hire employees, including legal counsel and a Tribal Relations Coordinator, and its main responsibilities include managing a grant program and carrying out tasks assigned by the Assistant Attorney General.

The section authorizes the Director of the Cannabis Justice Office to create a grant program called the “Community Reinvestment Grant Program.” This program provides funding to eligible organizations for services like job training, reentry services, legal aid, literacy programs, youth programs, and health education, aimed at helping those harmed by the War on Drugs.

The text defines key terms related to a bill concerning cannabis and its social impact. It includes definitions for “cannabis conviction,” types of “eligible entities” like certain nonprofits and Native groups, and who qualifies as an “individual adversely impacted by the War on Drugs.”

The bill section updates existing laws to include stimulants and broader substance use disorders alongside opioids. It allocates $200 million annually from 2025 to 2029 to fund related programs for these issues.

The proposed amendments to the Small Business Act ensure that cannabis-related legitimate businesses and service providers can access Small Business Administration programs and services without facing discrimination. This includes eligibility for financial support such as loans, grants, and assistance from development centers, despite being involved in legal cannabis activities.

The section states that the Administrator cannot refuse to buy or support loans for small business investment firms just because they help businesses involved in legal cannabis activities. Similarly, these investment companies must not withhold assistance from small businesses solely because they are involved in legal cannabis operations.

The section allows loans and assistance to be given to companies working with cannabis, stating that they cannot be denied just because they are connected to lawful cannabis activities, according to the Small Business Act. This means businesses involved with cannabis can receive financial support like other businesses.

The section requires the Bureau of Labor Statistics to gather and publicly release data on the demographics of cannabis business owners and employees, covering aspects like age, education, and race. It ensures that personal details like names and addresses remain confidential while also defining key terms like "cannabis industry" and "State".

The text describes a pilot program that allows the Administrator to make direct loans of up to $10 million each to eligible nonprofit organizations or financial institutions over a 20-year term, with rules set for interest rates and loan limits. The program aims to help small business startups, particularly those owned by individuals affected by the War on Drugs or socially and economically disadvantaged groups, through loans and additional support services like marketing and management.

The section aims to eliminate unfair treatment of cannabis-related businesses and service providers by reviewing and possibly changing Small Business Administration rules to reduce obstacles and enhance loan opportunities, especially for minority businesses and those affected by the War on Drugs. This may include looking at successful state-level programs as examples.

This section of the bill provides for the expungement of federal cannabis convictions for individuals not serving a criminal sentence, allowing them to treat such convictions as if they never happened and protecting them from related penalties. It includes various processes and conditions for expungement, a required demographic study of those previously convicted, and a report to Congress on the study's findings.

People cannot be denied federal benefits or security clearances just because they've used or possessed cannabis, or because of any past cannabis-related legal issues.

For immigration purposes, cannabis is not considered a controlled substance, and people cannot be denied immigration benefits due to cannabis-related activities. The Immigration and Nationality Act is amended to remove distinctions based on offences related to small amounts of marijuana, ensuring that removal orders and eligibility for benefits are not adversely affected by cannabis-related issues.

The section requires the Secretary of Veterans Affairs to update policies so that Department of Veterans Affairs health care providers can offer veterans advice about joining cannabis programs and fill out any necessary forms. These updates must be completed within 180 days after the law is passed.

The section requires the Director of the Indian Health Service to update regulations and policies to allow healthcare providers to give recommendations and opinions about patients' participation in State or Tribal cannabis programs. Providers can also complete forms related to those recommendations.

The section establishes a trust fund called the Opportunity Trust Fund, funded by taxes on cannabis products. It outlines various tax regulations for cannabis producers, importers, and distributors, including penalties for non-compliance, and mandates regular studies on the cannabis industry and tax impacts.

The section imposes a tax on cannabis products produced or imported into the United States, with a varying percentage based on the years since the law's implementation. It also provides a credit to domestic manufacturers, allowing them to reduce their tax by half up to a certain amount, but excludes credit for illegally produced, imported, or improperly bonded cannabis.

The section defines terms related to cannabis products and businesses, such as what qualifies as cannabis, how a producer is categorized, and the meaning of an importer and export warehouse proprietor within the context of cannabis. It also explains what activities are included in producing cannabis and describes what "removal" of cannabis products entails.

The section outlines the tax responsibilities and payment methods for producers and importers of cannabis products. It details scenarios where tax liability shifts between parties, the timing for tax payments, special rules for small taxpayers and imported goods, the use of electronic fund transfers for large tax liabilities, and how taxes are calculated for sales at non-market prices or on installment plans.

Cannabis products can be moved around or out of the country without paying taxes if they are used for scientific research, development, non-consumption purposes by government bodies, or under special conditions like being moved between producers. These rules are strictly controlled by the Secretary's regulations, and cannabis must be properly labeled.

This section outlines the rules for cannabis enterprises to receive a credit, refund, or drawback on taxes paid for cannabis products that are withdrawn from the market, lost, or destroyed due to unforeseen events like fire or natural disasters. It details the circumstances under which taxes are not collected or are refundable, including exceptions for theft, voluntary destruction, or unexplained shortages, and specifies time limits for filing claims.

Any person who uses cannabis to legally make drugs or extracts with a THC concentration within limits can get a tax refund for the cannabis used. They must register, keep records, and follow rules established by the Secretary. The tax refund rate is 90% and claims must be filed within six months. Even if some requirements aren't met, refunds may still be granted if proper use of the cannabis is proven, but a penalty may apply for not meeting requirements.

Under this section, cannabis products can only be produced at facilities authorized by the Secretary and bonded for compliance with regulations. Before starting operations, producers must apply for permission, provide a bond, and receive authorization. Individuals using cannabis for personal reasons, however, are not subject to these rules.

The application described in this section must include information required by the Secretary's regulations to determine the premises' location and operations, ensuring they follow laws and rules, as needed by the Federal Alcohol Administration Act.

A cannabis production facility must be located, built, and equipped in a way that ensures proper protection of government revenue, as directed by rules the Secretary establishes.

Cannabis businesses are required to create accurate inventories when they start or stop operations, and at other times as specified by the Secretary. They must also prepare reports and maintain records according to regulations, all of which can be checked by internal revenue officers.

The section outlines rules for packaging and labeling cannabis products, specifying that they must be packaged and labeled as per the regulations set by the Secretary. It prohibits any lottery-related items and indecent material from being included in or on the packages, with certain exceptions for products used for experiments or transferred to specific locations.

This section outlines rules for buying, receiving, possessing, selling, or disposing of cannabis products after they've been taken from their original place. It prohibits these actions if the taxes haven't been paid, if the products are not in proper packages, or if they have been taken for uses other than specified. If someone breaks these rules, they must pay the owed taxes on these products. However, selling directly to consumers from proper packages is allowed.

Anyone who tries to trick the United States by changing, removing, or destroying any required mark, label, or notice on a package of cannabis products before it is empty is breaking the law. This rule ensures that the correct information stays on the package until all the product is gone.

Cannabis products made in the U.S. and labeled for export can only be brought back to the U.S. after export if they meet specific tax and customs rules, and they can't be sold for domestic use unless they're repackaged without export labels by the original producer. The rules also apply if someone else changes the packaging, and shipping to Puerto Rico is considered exportation.

In the given section, anyone who fails to comply with the duties required by the chapter, such as not paying taxes on time or selling cannabis products illegally for export, can face serious penalties. These penalties might include fines of up to $10,000 or more, and in case of illegal cannabis sales, even the forfeiture and destruction of products and the means used for transport.

Anyone who tries to cheat the U.S. government by running a cannabis business without permission, not keeping required records, avoiding taxes, selling cannabis against the rules, or dealing with untaxed cannabis products can be fined up to $10,000 or sent to prison for up to 5 years. Additionally, people who have cannabis in violation of these rules must pay the tax on those products.

The Opportunity Trust Fund is a special fund established in the U.S. Treasury, which consists of money allocated to it by specific laws. It receives money from certain taxes, and some of this money is periodically transferred to the general Treasury to support initiatives under the Cannabis Administration and Opportunity Act.

The proposed legislation aims to regulate cannabis products through the Federal Food, Drug, and Cosmetic Act, establishing guidelines for the creation of a Center for Cannabis Products within the FDA. It defines rules for ensuring cannabis products are not adulterated or misbranded, requires registration for producers, sets standards for manufacturing and sale, prohibits certain flavored electronic cannabis devices, and allows states and tribes to impose stricter laws if they choose.

The Cannabis Administration and Opportunity Act requires the Secretary to create a new Center for Cannabis Products within the Food and Drug Administration within 90 days. This new Center will handle responsibilities related to cannabis and will report directly to the Commissioner of Food and Drugs, just like other centers in the FDA.

A cannabis product is considered adulterated if it contains harmful substances, is produced in unsanitary conditions, or uses unsafe color additives. However, food products that meet requirements for both food and cannabis aren't considered adulterated just because they contain cannabis, nor are they treated as foods with added drugs solely because they have cannabis ingredients.

A cannabis product is considered misbranded if its labeling is false or misleading; does not clearly state it contains cannabis and other required details like the manufacturer and THC content; makes unsubstantiated health claims; fails to display necessary warnings or instructions conspicuously; does not comply with cannabis product standards or legal requirements; is produced in an unregistered facility; or is intended for use by anyone under 21 years old.

Every year, people who own or run places where cannabis products are made in the U.S. must register with the Secretary, including naming the products they make, and foreign establishments that import cannabis must do the same. They need to keep this information up-to-date with any changes and the Secretary will make this information public and available to specific government departments.

The section outlines the rules for controlling the sale and promotion of cannabis products, focusing on preventing sales to anyone under 21 years old. It requires regulations for online sales, advertising, and good manufacturing practices, and emphasizes consultation with Indian Tribes in creating these regulations.

The section outlines that the Secretary will create rules for cannabis product standards to protect public health. These rules will cover things like product ingredients, testing requirements, labeling, and ensuring foreign cannabis meets the same standards as domestic cannabis. The standards will be reviewed and updated periodically based on new scientific data.

If the Secretary determines that a cannabis product might seriously harm health or cause death, they can stop its distribution and consider recalling it. The recall wouldn't involve individuals returning the product, but there would be notifications to warn people of the risks, with help from sellers and distributors.

Every cannabis product manufacturer or importer must keep records, make reports, and provide information as required by the Secretary to ensure the products are safe and adequately labeled. If they need to remove or fix a product due to health risks or legal violations, they must report it, unless it's already covered in other reports.

Any electronic device used to deliver cannabis through vapor must not have any flavors added, such as mint, mango, or vanilla, except for the natural flavor of cannabis itself. The term "electronic cannabis product delivery system" includes any related parts or liquids, whether sold together or separately.

The section ensures that federal laws about cannabis don't override or limit the power of state, tribal, and local governments to make their own strict laws about cannabis, including areas like its manufacture, sale, and use. It also clarifies that the chapter does not affect existing state or tribal laws about product liability or taxes on cannabis products.

The section introduces amendments to the Federal Food, Drug, and Cosmetic Act to define and regulate cannabis and cannabis products. It details the definition of cannabis, sets the legal age for sale, specifies prohibited acts involving cannabis products, and extends existing regulatory measures to include cannabis in areas like seizure, inspection, and import/export procedures.

The expedited review section of the bill establishes a program designed to speed up the development and review of drugs containing cannabis, especially those produced by small businesses run by disadvantaged groups or Native entities in the cannabis industry. It outlines steps for applying for expedited review, sets criteria, and mandates guidance on implementing the process, while defining relevant terms such as "drug containing cannabis" and "Native entity."

The section establishes a program to speed up the review of drug applications containing cannabis, particularly for small businesses owned by socially and economically disadvantaged individuals or Native entities in the cannabis industry. It outlines the process to request expedited review, potential actions to facilitate the review, and plans for future guidance on this program.

The section outlines requirements for any application concerning drugs containing cannabis. It mandates that applicants implement effective measures to prevent theft and misuse, with the possibility of including a risk evaluation strategy if deemed necessary by the Secretary, who will also set the standards for these measures.

The section outlines how cannabidiol (CBD) can be regulated as a dietary supplement and a food additive. It states that CBD from hemp can be included in supplements if it meets certain criteria set by the Secretary of Health and Human Services, including rules about cannabidiol amounts, packaging, and labeling. Additionally, the section details measures related to prohibiting interstate commerce of non-compliant CBD products, guidance on CBD as a food additive, and seeking input from experts through an advisory committee.

The section provides a transition period during which certain cannabis products and drugs containing cannabis, previously marketed under state law, can continue being sold without violating federal law, under specific conditions. To keep marketing these drugs, manufacturers must submit a new drug application within 18 months of the Act taking effect, but if the application is not approved, the drug cannot continue to be marketed; after three years, federal enforcement actions may be taken if the drug is found in violation.

The section modifies the Poison Prevention Packaging Act to include cannabis products in the list of items that require special packaging for safety, alongside cosmetics.

The bill allocates $425 million each year from 2025 to 2029 for the FDA to carry out activities specified in this part of the legislation, using funds from the U.S. Treasury that aren't already designated for other purposes.

The section outlines the regulations for the legal business of importing, manufacturing, and selling cannabis in the United States, requiring a permit from the Secretary, which includes conditions relating to compliance with federal and state laws, payment of taxes, and labor laws. It also describes processes for issuing permits, penalties for violations, and defines terms like "cannabis" and "Secretary."

Under SEC. 301, the bill states that it is illegal to import, cultivate, manufacture, package, warehouse, or purchase cannabis for resale without a permit from the Secretary. However, if someone applies for a permit within 90 days of receiving guidance from the Secretary, they can operate temporarily while their application is being reviewed, as long as they follow relevant regulations and pay any required taxes.

The section describes the process for issuing permits for cannabis operations, outlining criteria for disqualification such as prior offenses, state law violations, or noncompliance with federal law. It details conditions for permit issuance, including fee requirements, compliance with labor laws, and potential penalties like suspension or revocation for violations, while also allowing applicants to seek judicial review or waiver of certain disqualifications under specific circumstances.

The section outlines that the Secretary, together with other officials, will create rules for legally delivering hemp that has too much THC by accident to permitted cannabis businesses. This applies to certain hemp produced before a set date by universities or agriculture departments and by other authorized producers.

The section outlines various unlawful practices related to the cannabis industry, including unfair competition tactics such as exclusive deals, commercial bribery, misleading labeling, and false advertising. It also covers exceptions for certain practices, compliance with federal laws, and alignment with state laws.

In this section, if someone violates section 301, they can be fined up to $1,000. However, the Secretary has the option to not refer the case for prosecution and instead settle for a payment of up to $500. Additionally, the Attorney General has the authority to take civil action to stop any violations of the title.

The section provides definitions for terms used in the bill: "cannabis" is defined according to the Cannabis Administration and Opportunity Act; "Secretary" refers to the Secretary of the Treasury or their delegate; and "State" includes the District of Columbia, Puerto Rico, and U.S. territories.

The bill allocates $100 million each year from 2025 to 2029 for the Alcohol, Tobacco, and Cannabis Tax and Trade Bureau to carry out specific sections of this Act, sections of the Internal Revenue Code, the Federal Alcohol Administration Act, and the Homeland Security Act of 2002.

This section of the bill defines key terms related to the cannabis industry, including "cannabis industry," "employee," "employer," "employer in the cannabis industry," "person," "Secretary," and "worker in the cannabis industry." It specifies the meanings of these terms by referencing other legal acts and sections for clarity.

Congress acknowledges that employers in the cannabis industry must follow the safety and health regulations outlined in the Occupational Safety and Health Act of 1970 and any additional related regulations.

The section mandates that for the two years after the law is passed, the Secretary must categorize cannabis as a key subject for Susan Harwood training grants, which are provided under the Occupational Safety and Health Act of 1970.

The section requires that, within 60 days, the Assistant Secretary of Labor for Occupational Safety and Health and the Director of the National Institute for Occupational Safety and Health jointly issue guidance to protect workers in the cannabis industry. This guidance must cover potential hazards, protective methods, and relevant safety standards and training requirements for the industry.

The section mandates a study by the National Institute for Occupational Safety and Health on the effects of state-level cannabis legalization on workplace safety, such as potential risks and safety measures in the cannabis industry. It also allocates $2 million annually from 2025 to 2027 for this research and requires the development of best practices for employers adjusting workplace policies related to recreational cannabis.

The section authorizes grants for nonprofit organizations to educate and support workers in the cannabis industry about their rights under various laws. The grants, lasting up to three years and not exceeding $300,000 each, aim to help low-wage workers and ensure compliance from employers, with $15 million allocated annually for 2025 to 2029.

The section outlines two main goals: to reinvest in areas and communities hit hardest by the war on drugs, and to motivate financial institutions to offer services to small or minority-owned businesses in those areas. It also expresses Congress's opinion that federal agencies should use their existing authority to encourage these financial institutions to meet local credit needs responsibly.

This section of the bill outlines specific requirements for banks and financial institutions when they handle transactions related to legal cannabis businesses. It mandates updates to guidance to ensure these businesses can access financial services without significant restrictions, while still maintaining measures to prevent illegal activities associated with cannabis money transactions.

The section mandates that within 180 days of the law's enactment, the Federal Financial Institutions Examination Council, collaborating with the Financial Crimes Enforcement Network, must create clear guidelines and inspection procedures for banks working with legal cannabis businesses. This must align with the updated guidance from the Financial Crimes Enforcement Network as specified in related legislation.

The section outlines financial support and funding for low or moderate-income communities from 2025 to 2029. It provides $200 million annually for Community Development Financial Institutions and Minority Depository Institutions to aid those affected by the war on drugs and allocates $300 million annually for grants addressing housing and community development for impacted individuals and areas.

All people should have equal access to financial services and cannot be discriminated against based on race, color, religion, national origin, or sex, including sexual orientation and gender identity. If someone believes they have been discriminated against, they can take legal action, and the courts have the authority to handle these cases, with various remedies available to ensure fair treatment.

Institutions cannot refuse to provide financial services to someone just because they have a past conviction for a nonviolent cannabis-related crime.

The Comptroller General is tasked with reviewing federal laws, regulations, and policies to see if they need any changes in line with a new Act's goals. This includes replacing the terms "marijuana" or "marihuana" with "cannabis" in official documents, and a report with recommendations should be submitted to Congress within two years.

The Cannabis Products Advisory Committee is established to advise federal agencies on administering cannabis-related laws. This 22-member committee, appointed by the Secretary of Health and Human Services, includes representatives from various sectors like public health, industry, and government. Members serve five-year terms, and the committee meets at least quarterly to consider policy recommendations, assess cannabis health impacts, and publish an annual report on their activities.

The section updates the definition of hemp in the Agricultural Marketing Act by allowing hemp products with a total THC concentration, including various forms of tetrahydrocannabinol, up to a specified limit. It also gives authorities the power to change these limits based on new findings about how these substances affect the body and allows exclusions for certain isomers of THC.

The section outlines amendments to the 1968 Omnibus Crime Control and Safe Streets Act, introducing grants for small law enforcement agencies to hire personnel for combating illegal cannabis activities and developing education programs for law enforcement on cannabis law enforcement. Additionally, $15 million is allocated annually from 2025 to 2029 to support these initiatives.

If any part of this law or its amendments is found to be unconstitutional, the rest of the law and its amendments will still remain valid and enforceable.